Published in Neuroimage on February 01, 2003
Default network activity, coupled with the frontoparietal control network, supports goal-directed cognition. Neuroimage (2010) 3.52
Default network modulation and large-scale network interactivity in healthy young and old adults. Cereb Cortex (2011) 1.31
Domain general and domain preferential brain regions associated with different types of task switching: a meta-analysis. Hum Brain Mapp (2011) 1.17
Common and distinct mechanisms of cognitive flexibility in prefrontal cortex. J Neurosci (2011) 1.14
The role of the lateral frontal cortex in causal associative learning: exploring preventative and super-learning. Cereb Cortex (2004) 1.09
Functional disconnection and compensation in mild cognitive impairment: evidence from DLPFC connectivity using resting-state fMRI. PLoS One (2011) 1.08
Dopamine supports coupling of attention-related networks. J Neurosci (2012) 1.07
Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson's disease. J Neurol Neurosurg Psychiatry (2005) 1.05
The boundaries of language and thought in deductive inference. Proc Natl Acad Sci U S A (2009) 1.01
Executive dysfunction in poor readers born prematurely at high risk. Dev Neuropsychol (2009) 0.99
The caudate: a key node in the neuronal network imbalance of insomnia? Brain (2013) 0.98
The influences of task difficulty and response correctness on neural systems supporting fluid reasoning. Cogn Neurodyn (2006) 0.92
A problem-solving task specialized for functional neuroimaging: validation of the Scarborough adaptation of the Tower of London (S-TOL) using near-infrared spectroscopy. Front Hum Neurosci (2014) 0.89
The Maudsley early onset schizophrenia study: cognitive function over a 4-year follow-up period. Schizophr Bull (2007) 0.88
Multimodal MRI and cognitive function in patients with breast cancer prior to adjuvant treatment--the role of fatigue. Neuroimage Clin (2015) 0.88
Brain activation during cognitive planning in twins discordant or concordant for obsessive-compulsive symptoms. Brain (2010) 0.87
Fractionating the neural substrates of transitive reasoning: task-dependent contributions of spatial and verbal representations. Cereb Cortex (2012) 0.83
Piccolo genotype modulates neural correlates of emotion processing but not executive functioning. Transl Psychiatry (2012) 0.81
Compensatory brain activation in children with attention deficit/hyperactivity disorder during a simplified Go/No-go task. J Neural Transm (Vienna) (2011) 0.81
Anterior cingulate cortex instigates adaptive switches in choice by integrating immediate and delayed components of value in ventromedial prefrontal cortex. J Neurosci (2014) 0.81
Neural Mechanisms of Hierarchical Planning in a Virtual Subway Network. Neuron (2016) 0.80
The role of the frontopolar cortex in manipulation of integrated information in working memory. Neurosci Lett (2015) 0.79
Influence of COMT val158met genotype on the depressed brain during emotional processing and working memory. PLoS One (2013) 0.79
Human brain basis of musical rhythm perception: common and distinct neural substrates for meter, tempo, and pattern. Brain Sci (2014) 0.79
Selective biasing of a specific bistable-figure percept involves fMRI signal changes in frontostriatal circuits: a step toward unlocking the neural correlates of top-down control and self-regulation. Am J Clin Hypn (2007) 0.79
Impaired planning in Parkinson's disease is reflected by reduced brain activation and connectivity. Hum Brain Mapp (2015) 0.78
The role of the right dorsolateral prefrontal cortex in the Tower of London task performance: repetitive transcranial magnetic stimulation study in patients with Parkinson's disease. Exp Brain Res (2012) 0.78
Autobiographical Planning and the Brain: Activation and Its Modulation by Qualitative Features. J Cogn Neurosci (2015) 0.77
Strategic cognitive sequencing: a computational cognitive neuroscience approach. Comput Intell Neurosci (2013) 0.76
Cognitive control, reward-related decision making and outcomes of late-life depression treated with an antidepressant. Psychol Med (2015) 0.76
Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type. PLoS One (2017) 0.75
Neuroimaging studies of the striatum in cognition Part I: healthy individuals. Front Syst Neurosci (2015) 0.75
Putative cortical dopamine levels affect cortical recruitment during planning. Neuropsychologia (2013) 0.75
Functional MR study of a motor task and the tower of London task at 1.0 T. Neuroradiology (2006) 0.75
A dual comparative approach: integrating lines of evidence from human evolutionary neuroanatomy and neurodevelopmental disorders. Brain Behav Evol (2014) 0.75
Impairment of a parieto-premotor network specialized for handwriting in writer's cramp. Hum Brain Mapp (2016) 0.75
Functional near-infrared spectroscopy in movement science: a systematic review on cortical activity in postural and walking tasks. Neurophotonics (2017) 0.75
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med (2010) 13.82
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18
Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci (2004) 5.55
Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med (2006) 5.20
Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan: Response. Radiology (2017) 4.99
Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy. Arch Gen Psychiatry (2006) 4.71
Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study. Hum Brain Mapp (2005) 4.11
PML in a patient treated with dimethyl fumarate from a compounding pharmacy. N Engl J Med (2013) 4.02
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet (2008) 3.93
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial. Lancet (2011) 3.76
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Patients' preferences in the treatment of depressive disorder in primary care. Gen Hosp Psychiatry (2004) 3.48
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol (2007) 3.47
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurol (2009) 3.42
Do rats have a prefrontal cortex? Behav Brain Res (2003) 3.38
The intralaminar and midline nuclei of the thalamus. Anatomical and functional evidence for participation in processes of arousal and awareness. Brain Res Brain Res Rev (2002) 3.21
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study. Lancet Neurol (2011) 3.16
The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics. Neurosci Biobehav Rev (2003) 2.87
Genome-wide association of major depression: description of samples for the GAIN Major Depressive Disorder Study: NTR and NESDA biobank projects. Eur J Hum Genet (2008) 2.75
Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. Arch Neurol (2011) 2.75
Chronic cerebrospinal venous insufficiency and multiple sclerosis. Ann Neurol (2010) 2.63
Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke (2005) 2.59
Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension. Hypertension (2009) 2.58
Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. Stroke (2008) 2.57
Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology (2005) 2.47
Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry (2010) 2.44
MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation". Lancet Neurol (2006) 2.44
Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain (2002) 2.30
Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). Arch Gen Psychiatry (2008) 2.30
Magnetic resonance imaging pattern recognition in hypomyelinating disorders. Brain (2010) 2.19
Whole brain resting-state analysis reveals decreased functional connectivity in major depression. Front Syst Neurosci (2010) 2.16
Loss of 'small-world' networks in Alzheimer's disease: graph analysis of FMRI resting-state functional connectivity. PLoS One (2010) 2.12
Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol (2005) 2.10
MRI in multiple sclerosis: current status and future prospects. Lancet Neurol (2008) 2.08
Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol (2005) 2.07
Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Mult Scler (2011) 2.07
Lack of association between antimyelin antibodies and progression to multiple sclerosis. N Engl J Med (2007) 2.06
Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry (2009) 2.00
Grey matter pathology in multiple sclerosis. Lancet Neurol (2008) 1.97
Longitudinal evidence for unfavorable effects of antidepressants on heart rate variability. Biol Psychiatry (2010) 1.95
Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet (2004) 1.93
Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: a randomized controlled trial. Am J Psychiatry (2007) 1.91
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke (2006) 1.88
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial. Lancet Neurol (2013) 1.84
Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum Brain Mapp (2010) 1.83
Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study. Neuroradiology (2007) 1.80
Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial. Lancet Neurol (2011) 1.79
Imaging markers for Alzheimer disease: which vs how. Neurology (2013) 1.76
Unusual variants of Alexander's disease. Ann Neurol (2005) 1.76
On the etiology of incident brain lacunes: longitudinal observations from the LADIS study. Stroke (2008) 1.75
Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol (2012) 1.70
Improved detection of active multiple sclerosis lesions: 3D subtraction imaging. Radiology (2010) 1.68
No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow-quantification study. J Neurol Neurosurg Psychiatry (2010) 1.68
Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder. Arch Gen Psychiatry (2006) 1.67
Accelerated aging, decreased white matter integrity, and associated neuropsychological dysfunction 25 years after pediatric lymphoid malignancies. J Clin Oncol (2013) 1.67
Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: a longitudinal study. Neurobiol Aging (2008) 1.67
Alcohol use disorders and the course of depressive and anxiety disorders. Br J Psychiatry (2012) 1.66
Why gamblers fail to win: a review of cognitive and neuroimaging findings in pathological gambling. Neurosci Biobehav Rev (2009) 1.66
A specific role of the human hippocampus in recall of temporal sequences. J Neurosci (2009) 1.66
Different brain effects during chronic and acute sacral neuromodulation in urge incontinent patients with implanted neurostimulators. BJU Int (2006) 1.65
Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol (2002) 1.64
Efficacy of self-help manuals for anxiety disorders in primary care: a systematic review. Fam Pract (2005) 1.63
Attentional bias and disinhibition toward gaming cues are related to problem gaming in male adolescents. J Adolesc Health (2011) 1.63
The orbital cortex in rats topographically projects to central parts of the caudate-putamen complex. Neurosci Lett (2007) 1.63
Microbleeds do not affect rate of cognitive decline in Alzheimer disease. Neurology (2012) 1.62
Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria. Ann Neurol (2005) 1.61
Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease. Alzheimers Dement (2011) 1.59
Model-free group analysis shows altered BOLD FMRI networks in dementia. Hum Brain Mapp (2009) 1.59
Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis. Arch Gen Psychiatry (2005) 1.58
Effects of modafinil on neural correlates of response inhibition in alcohol-dependent patients. Biol Psychiatry (2012) 1.58
Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition. Stroke (2009) 1.57
Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis. Neurology (2012) 1.57
Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease. J Alzheimers Dis (2012) 1.57
A new leukoencephalopathy with brainstem and spinal cord involvement and high lactate. Ann Neurol (2003) 1.57
White matter tract integrity in aging and Alzheimer's disease. Hum Brain Mapp (2009) 1.57
Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients. Radiology (2008) 1.56
Response perseveration and ventral prefrontal sensitivity to reward and punishment in male problem gamblers and smokers. Neuropsychopharmacology (2008) 1.56
A randomized trial of cognitive-behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia: treatment results through 1-year follow-up. J Clin Psychiatry (2010) 1.54
Resting-state fMRI changes in Alzheimer's disease and mild cognitive impairment. Neurobiol Aging (2011) 1.54
Diffusion changes predict cognitive and functional outcome: the LADIS study. Ann Neurol (2013) 1.54
SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. Am J Psychiatry (2002) 1.54
Histopathologic correlates of radial stripes on MR images in lysosomal storage disorders. AJNR Am J Neuroradiol (2005) 1.53
Frontal-striatal dysfunction during planning in obsessive-compulsive disorder. Arch Gen Psychiatry (2005) 1.53
Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch Intern Med (2007) 1.52
The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. Brain (2008) 1.52
Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus. J Neurol Neurosurg Psychiatry (2013) 1.52
Developmental aspects of error and high-conflict-related brain activity in pediatric obsessive-compulsive disorder: a fMRI study with a Flanker task before and after CBT. J Child Psychol Psychiatry (2011) 1.51
Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease. Neurology (2013) 1.51
Modafinil modulates resting-state functional network connectivity and cognitive control in alcohol-dependent patients. Biol Psychiatry (2013) 1.49
Functional magnetic resonance imaging during planning before and after cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry (2010) 1.47